March 12, 2025 |
Methanex Corporation (MEOH)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Methanex Corporation (“Methanex” or “the Company”) (NASDAQ: MEOH). Investors who purchased Methanex securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Methanex has violated federal… read more
March 11, 2025 |
Robinhood Markets, Inc. (HOOD)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Robinhood Markets, Inc. (“Robinhood” or “the Company”) (NASDAQ: HOOD). Investors who purchased Robinhood securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Robinhood has violated… read more
March 10, 2025 |
Caribou Biosciences, Inc. (CRBU)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Caribou Biosciences, Inc. (“Caribou” or “the Company”) (NASDAQ: CRBU). Investors who purchased Caribou securities prior to July 14, 2023, and continue to hold to the present, are encouraged to obtain additional… read more
March 4, 2025 |
NVIDIA Corporation (NVDA)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NVIDIA Corporation (“NVIDIA” or “the Company”) (NASDAQ: NVDA). Investors who purchased NVIDIA securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether NVIDIA has violated federal… read more
February 25, 2025 |
CrowdStrike Holdings, Inc. (CRWD)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CrowdStrike Holdings, Inc. (“CrowdStrike” or “the Company”) (NASDAQ: CRWD). Investors who purchased CrowdStrike securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether CrowdStrike has violated… read more
February 25, 2025 |
Akamai Technologies, Inc. (AKAM)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akamai Technologies, Inc. (“Akamai” or “the Company”) (NASDAQ: AKAM). Investors who purchased Akamai securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Akamai has violated… read more
February 24, 2025 |
The Lion Electric Company (LEVGQ)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Lion Electric Company (“Lion Electric” or “the Company”) (OTCMKTS: LEVGQ). Investors who purchased Lion Electric securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
February 19, 2025 |
Septerna, Inc. (SEPN)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Septerna, Inc. (“Septerna” or “the Company”) (NASDAQ: SEPN). Investors who purchased Septerna securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Septerna has violated federal… read more
February 18, 2025 |
Synchrony Financial (SYF)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Synchrony Financial (“Synchrony” or “the Company”) (NYSE: SYF). Investors who purchased Synchrony securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Synchrony has violated federal… read more
February 13, 2025 |
Pliant Therapeutics, Inc. (PLRX)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pliant Therapeutics, Inc. (“Pliant” or “the Company”) (NASDAQ: PLRX). Investors who purchased Pliant securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Pliant has violated… read more
February 13, 2025 |
STAAR Surgical Company (STAA)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of STAAR Surgical Company (“STAAR” or “the Company”) (NASDAQ: STAA). Investors who purchased STAAR securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether STAAR has violated… read more
February 13, 2025 |
Harmonic Inc. (HLIT)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Harmonic Inc. (“Harmonic” or “the Company”) (NASDAQ: HLIT). Investors who purchased Harmonic securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Harmonic has violated federal… read more
February 12, 2025 |
Pagaya Technologies Ltd. (PGY)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pagaya Technologies Ltd. (“Pagaya” or “the Company”) (NASDAQ: PGY). Investors who purchased Pagaya securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Pagaya has violated… read more
February 11, 2025 |
Harmonic Inc. (HLIT)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Harmonic Inc. (“Harmonic” or “the Company”) (NASDAQ: HLIT). Investors who purchased Harmonic securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Harmonic has violated federal… read more
February 7, 2025 |
Eldorado Gold Corporation (EGO)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Eldorado Gold Corporation (“Eldorado” or “the Company”) (NYSE: EGO). Investors who purchased Eldorado securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Eldorado has violated… read more
February 7, 2025 |
Huntington Ingalls Industries, Inc. (HII)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Huntington Ingalls Industries, Inc. (“Huntington Ingalls” or “the Company”) (NYSE: HII). Investors who purchased Huntington Ingalls securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
February 7, 2025 |
Huntington Ingalls Industries, Inc. (HII)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Huntington Ingalls Industries, Inc. (“Huntington Ingalls” or “the Company”) (NYSE: HII). Investors who purchased Huntington Ingalls securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
February 5, 2025 |
Premier, Inc. (PINC)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Premier, Inc. (“Premier” or “the Company”) (NASDAQ: PINC). Investors who purchased Premier securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Premier has violated federal… read more
February 4, 2025 |
DMC Global Inc. (BOOM)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DMC Global Inc. (“DMC Global” or “the Company”) (NASDAQ: BOOM). Investors who purchased DMC Global securities prior to January 29, 2024, and continue to hold to the present, are encouraged to… read more
February 4, 2025 |
Five9, Inc. (FIVN)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Five9, Inc. (“Five9” or “the Company”) (NASDAQ: FIVN). Investors who purchased Five9 securities prior to June 4, 2025, and continue to hold to the present, are encouraged to obtain additional information… read more
February 4, 2025 |
Customers Bancorp, Inc. (CUBI)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Customers Bancorp, Inc. (“Customers Bancorp” or “the Company”) (NYSE: CUBI). Investors who purchased Customers Bancorp securities prior to March 1, 2024, and continue to hold to the present, are encouraged to… read more
February 4, 2025 |
ASP Isotopes Inc. (ASPI)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. (“ASP Isotopes” or “the Company”) (NASDAQ: ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to… read more
February 4, 2025 |
Owens & Minor, Inc. (OMI)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Owens & Minor, Inc. (“Owens & Minor” or “the Company”) (NYSE: OMI). Investors who purchased Owens & Minor securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
February 3, 2025 |
Olin Corporation (OLN)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Olin Corporation (“Olin” or “the Company”) (NYSE: OLN). Investors who purchased Olin securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Olin has violated federal… read more
January 30, 2025 |
Evolv Technologies Holdings, Inc. (EVLV)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Evolv Technologies Holdings, Inc. (“Evolv Technologies” or “the Company”) (NASDAQ: EVLV). Investors who purchased Evolv Technologies securities prior to August 19, 2022, and continue to hold to the present, are encouraged… read more
January 30, 2025 |
CARGO Therapeutics, Inc. (CRGX)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CARGO Therapeutics, Inc. (“CARGO” or “the Company”) (NASDAQ: CRGX). Investors who purchased CARGO securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether CARGO has violated… read more
January 29, 2025 |
Acadia Healthcare Company, Inc. (ACHC)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. (“Acadia Healthcare” or “the Company”) (NASDAQ: ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged… read more
January 29, 2025 |
Flux Power Holdings, Inc. (FLUX)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Flux Power Holdings, Inc. (“Flux” or “the Company”) (NASDAQ: FLUX). Investors who purchased Flux securities prior to November 11, 2022, and continue to hold to the present, are encouraged to obtain… read more
January 29, 2025 |
Dentsply Sirona Inc. (XRAY)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. (“Dentsply” or “the Company”) (NASDAQ: XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional… read more
January 27, 2025 |
Midland States Bancorp, Inc. (MSBI)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Midland States Bancorp, Inc. (“Midland States Bancorp” or “the Company”) (NASDAQ: MSBI). Investors who purchased Midland States Bancorp securities are encouraged to obtain additional information and assist the investigation. The investigation… read more